Sirna Therapeutics said last week that it has named Martin Schmieg as senior vice president and CFO.
Schmieg will direct and oversee Sirna’s financial management, accounting activities, and investor and public relations, and will begin at the company on Sept. 20.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
